Schizophrenia: Etiology, Prevalence, and Evidence-Based Treatments
This paper provides a comprehensive overview of schizophrenia, tracing its conceptual history from ancient civilizations through modern clinical frameworks. It examines competing etiological theories — biological, genetic, physiological, and sociocultural — and surveys the global and domestic prevalence of the disorder, with attention to differences across developed and developing nations, gender, age, and ethnicity. The paper also reviews DSM-V diagnostic criteria, discusses controversies surrounding pharmaceutical influence on diagnosis, and evaluates evidence-based treatments including antipsychotic pharmacotherapy and psychosocial interventions. It concludes by arguing that the lower dropout rate and stronger clinical outcomes of psychosocial treatment suggest schizophrenia may be fundamentally social in nature, warranting greater focus from a sociological perspective.
- Introduction: Historical framing of schizophrenia across cultures and time
- Etiology: Competing biological, genetic, and sociocultural causal theories
- Prevalence: Global and demographic distribution of schizophrenia cases
- Diagnostic Criteria: DSM-V criteria and pharmaceutical influence on diagnosis
- Treatments: Pharmacological, psychoanalytic, and psychosocial treatment approaches
- Conclusion: Case for prioritizing sociological perspective in future research
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Integrates historical and contemporary perspectives on schizophrenia, showing continuity of inquiry across cultures and centuries rather than treating modern psychiatry in isolation.
- Uses a wide range of peer-reviewed sources to support multiple competing theories of etiology, demonstrating intellectual balance rather than advocacy for a single position.
- Connects empirical findings — such as dropout rates and immigrant schizophrenia rates — directly to the paper's concluding argument about the sociological dimension of the disease.
- Critically engages with institutional influences on diagnosis, raising questions about pharmaceutical industry pressure on DSM-V classifications without abandoning academic tone.
Key academic technique demonstrated
The paper exemplifies the synthesis move: rather than reporting each source in isolation, the author weaves findings from epidemiology, neuroscience, cultural studies, and treatment research into a cumulative argument. Each section builds evidentiary weight for the final claim that psychosocial, not biological, factors may be primary in schizophrenia — a conclusion that is prepared throughout the body rather than introduced only at the end.
Structure breakdown
The paper follows a classic academic structure: an introduction that frames scope and thesis direction; a historical-to-modern etiology section; a prevalence section that moves from global to domestic to demographic data; a diagnostic criteria section with critical commentary; a treatments section covering pharmacological, psychoanalytic, and psychosocial approaches; and a conclusion that synthesizes all sections into a policy-relevant claim. Each section is self-contained yet contributes to the overarching argument.
Introduction
Eugen Bleuler first used the term "schizophrenia" in the early 20th century as a means of redefining what earlier psychologists had described as a form of dementia. Bleuler's term described a "split mind" — a phenomenon that was not new to the world but had in fact existed for thousands of years (Kyziridis, 2005). Cultures and societies as disparate as the ancient Chinese and the ancient Romans had attempted to identify, understand, and treat the mental or, as some philosophers called it, spiritual sickness. Techniques, treatments, and discussions of the phenomenon that today is classified as "schizophrenia" have therefore differed over time and place throughout all of history. This paper discusses what researchers now state regarding the etiology of schizophrenia, the prevalence of the disorder, the modern diagnostic criteria, and the evidence-based treatments currently in use.
Etiology
The most comprehensive etiological examination of schizophrenia incorporates both the historical and the modern academic perspective. To limit one's analysis to the Bleuler or Kraepelin school is to dismiss thousands of years of critical scrutiny that came before.
The ancient Egyptians viewed mental disease as a physical illness, while Plato and the ancient Chinese understood psychotic episodes as consequences of spiritual disturbances (Kyziridis, 2005, p. 42–3). The ancient Hindu texts associate mental health with a balance of spiritual and physical well-being, and the Middle Ages saw various approaches to mental disorders, indicating that causes were believed to be physical, psychological, and spiritual in nature.
Freud attempted to interpret a cause for the split-mind phenomenon by stressing a relationship "between family dynamics and schizophrenia" (Kyziridis, 2005, p. 46). Modern researchers such as Dr. Nimgaonkar (2006) focus on genetic causes, while others, like Marenco and Weinberger (2000), locate schizophrenia's cause in utero (p. 501). Nimgaonkar (2006) states that "literally hundreds of causes have been proposed" but that the best etiological theory is hereditary, suggesting that the root cause of schizophrenia is biological.
McGuire, David, et al. (1995) state that "auditory verbal hallucinations ('voices') are thought to arise from a disorder of inner speech (thinking in words)," indicating that this particular sign of schizophrenia points to a physiological cause. The "predisposition to verbal hallucinations is associated with a failure to activate areas concerned with the monitoring of inner speech," which is situated in the physiology of the brain (p. 596). When examining the neural correlates of tasks involving inner speech in subjects with schizophrenia who hear voices, as well as in non-hallucinators, McGuire et al. determined that blood flow in the brain differed between the two groups during thought processes.
Thus, the etiology of schizophrenia continues to be unknown, though theories vary widely about its origins and causes.
Prevalence
Part of the difficulty in discussing the prevalence of schizophrenia is that the disorder can often be misdiagnosed. Because its symptoms at various stages of development resemble those of other mental diseases, a definitive diagnosis can be hard to make. Different cultures also hold different views of diagnosis and treatment, meaning there is no uniform approach to schizophrenia across the globe.
For instance, a study based on a long-term survey of schizophrenia in more than a dozen countries conducted by the World Health Organization found "that patients in countries outside Europe and the United States have a more favorable short- and medium-term course of the disease than those seen in developed countries" (Sartorius, Gulbinat, Harrison, Laska, & Siegel, 1996, p. 249). The study indicates that the prevalence of schizophrenia at the end of the 20th century appears to be far greater in the Western world than in the non-Western world, where cultural norms and values differ and diagnostic methods are not approached as uniformly or as institutionally as in the West.
Bhugra (2005) states that the prevalence of schizophrenia in the developing world is actually far less than in the industrialized Western world. This finding suggests that the etiology of schizophrenia may have more to do with cultural and social surroundings than with genetics or physiology. The fact that mental disorders are more prevalent in the industrialized West may be an example of how a split mind can arise from the split between individuals and their natural environment. At the same time, the disparity may also be accounted for by differences in diagnostic methods: 1% of schizophrenia cases in the developed world were diagnosed as catatonia, compared to 10% in developing regions. Hebephrenia was diagnosed in 13% of cases in developed countries, as opposed to 4% in developing regions.
One argument against these findings is that most cases, whether in developed or developing countries, were diagnosed in Western-style facilities — a factor that may distort the actual number of cases, since "hospital-based data collection reflects cultural processes that have little to do with the true prevalence and incidence rates of schizophrenia" (Bhugra, 2005, p. 151). Another argument is that acute-onset schizophrenia in developing countries is actually double that of the industrialized world, suggesting that schizophrenia is equally prevalent in the developing world and that diagnosis is simply slow in coming.
Bhugra notes that cross-cultural studies have been effective in helping to better understand the etiology of schizophrenia, but that cultural identities may compromise the authenticity of such surveys in settings where individuals are less likely to be observed in Western-style facilities.
Smith (2007) states that "schizophrenia is the clinical centerpiece of psychiatry" (p. 76). Illustrating how prevalent the disease is in the United States, Smith notes that it "accounts for half of all admissions to psychiatric hospitals, costs $40 billion a year to treat in the United States, and is one of the top ten causes of disability worldwide" (p. 77). As more nations undergo industrialization, it may be significant that the number of cases of schizophrenia has risen correspondingly.
On the other hand, Messias, Chen, and Eaton (2007) found that in England, "those immigrating from Africa or the Caribbean, and their second-generation offspring, have rates of schizophrenia up to ten times higher than those in the general population" (p. 327). Messias, Chen, and Eaton argue that the disease is unlikely to be caused solely by the stress of immigration or of adapting to a foreign culture, though they do contend that the etiology in these cases is likely to be found in the psychological effects of being a racial minority in an ethnically white nation. This finding again suggests that the split-mind phenomenon may result from a split between individuals and their social surroundings.
According to the World Health Organization's latest findings, approximately 24 million people around the globe are affected by schizophrenia at some point in their lives. Castle, Wessely, Der, and Murray (1991) note that schizophrenia is 1.4 times more likely to be found in men than in women, and that the most common ages for onset are the young adult years of 20–28 for men and 26–32 for women. Schizophrenia is not typically found in children or older individuals.
Conclusion
Schizophrenia remains a mystery in its causes and in its cure. Various treatments and approaches have shown to be effective; however, there is no single solution or treatment that has proven 100% effective. Moreover, the finding that most cases of schizophrenia occur in young adults at a pivotal point in their lives — when they must emerge from adolescence and engage with the world as functioning adults — may indicate that schizophrenia is a social disease caused by an inability to meet the social standards set forth by a community or social environment. The split-mind phenomenon is not new to the world, and an exploration of how history has treated and viewed it may reveal useful lessons for modern researchers.
Today's findings that psychosocial treatments are more effective than pharmaceutical approaches suggest that the social dimension of schizophrenia deserves greater focus from researchers. The sociological aspect of the disease may be of more significance than the biological, genetic, or physiological findings that have dominated recent decades of research. Nonetheless, the ultimate approach to schizophrenia remains open.
References
Bhugra, D. (2005). The global prevalence of schizophrenia. PLoS Med, 2(5): 151.
Castle, D., Wessely, S., Der, G., & Murray, R. (1991). The incidence of operationally defined schizophrenia in Camberwell, 1965–1984. The British Journal of Psychiatry, 159: 790–4.
Hofstede, G., & Minkov, M. (2010). Cultures and organizations: Software of the mind (3rd ed.). McGraw-Hill.
Kyziridis, T. (2005). Notes on the history of schizophrenia. German Journal of Psychiatry, 8: 42–8.
Marenco, S., & Weinberger, D. (2000). The neurodevelopmental hypothesis of schizophrenia: Following a trail of evidence from cradle to grave. Development and Psychopathology, 12(3): 501–527.
McGuire, P. K., David, A. S., et al. (1995). Abnormal monitoring of inner speech: A physiological basis for auditory hallucinations. The Lancet, 346: 596–600.
Messias, E., Chen, C., & Eaton, W. (2007). Epidemiology of schizophrenia: Review of findings and myths. Psychiatric Clinics of North America, 30(3): 323–338.
Nimgaonkar, V. (2006). Causes of schizophrenia. University of Pittsburgh.
Sartorius, N., Gulbinat, W., Harrison, G., Laska, E., & Siegel, C. (1996). Long-term follow-up of schizophrenia in 16 countries. Social Psychiatry and Psychiatric Epidemiology, 31(5): 249–58.
Smith, D. (2007). Muses, madmen, and prophets: Hearing voices and the borders of sanity. Penguin Books.
Villeneuve, K., Potvin, S., Lesage, A., & Nicole, L. (2010). Meta-analysis of rates of drop-out from psychosocial treatment among persons with schizophrenia spectrum disorder. Schizophrenia Research, 121(1–3): 266–70.
Create your account
Always verify citation format against your institution’s current style guide requirements.